BNC1 has been shown to be silenced by promoter methylation in a wide variety of tumors, including pancreatic cancer, renal cell carcinoma, lung cancer, lymphocytic leukemia and the metastatic brain tumors originating from primary breast tumors [9,10,11,12,13]. Here, BNC1 is linked to lung cancer.